Abstract
The use of oral anticancer agents for the treatment of common malignancies has increased over the past few years. Of about 300 new anticancer agents in development, 20-25% are oral...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
